KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Elevance Health (ELV) over the last 17 years, with Q4 2025 value amounting to $7.3 billion.

  • Elevance Health's Accounts Payables rose 570.23% to $7.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $7.3 billion, marking a year-over-year increase of 570.23%. This contributed to the annual value of $7.3 billion for FY2025, which is 570.23% up from last year.
  • Elevance Health's Accounts Payables amounted to $7.3 billion in Q4 2025, which was up 570.23% from $6.1 billion recorded in Q3 2025.
  • Elevance Health's 5-year Accounts Payables high stood at $7.3 billion for Q4 2025, and its period low was $4.9 billion during Q1 2023.
  • Moreover, its 5-year median value for Accounts Payables was $5.8 billion (2022), whereas its average is $5.9 billion.
  • As far as peak fluctuations go, Elevance Health's Accounts Payables plummeted by 1672.82% in 2022, and later surged by 2635.42% in 2025.
  • Quarter analysis of 5 years shows Elevance Health's Accounts Payables stood at $5.0 billion in 2021, then increased by 12.82% to $5.6 billion in 2022, then grew by 23.24% to $6.9 billion in 2023, then rose by 0.25% to $6.9 billion in 2024, then grew by 5.7% to $7.3 billion in 2025.
  • Its last three reported values are $7.3 billion in Q4 2025, $6.1 billion for Q3 2025, and $7.3 billion during Q2 2025.